The US Regulatory System and COVID-19 Vaccines: The Importance of a Strong and Capable FDA
JAMA
.
2021 Mar 23;325(12):1153-1154.
doi: 10.1001/jama.2021.1961.
Authors
Joshua M Sharfstein
1
,
Jesse L Goodman
2
,
Luciana Borio
3
Affiliations
1
Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
2
Medicine and Infectious Diseases, Georgetown University, Washington, DC.
3
In-Q-Tel, Arlington County, Virginia.
PMID:
33587124
DOI:
10.1001/jama.2021.1961
No abstract available
MeSH terms
COVID-19 / prevention & control*
COVID-19 Vaccines*
Drug Approval
Government Regulation*
Humans
Public Opinion
United States
United States Food and Drug Administration*
Substances
COVID-19 Vaccines